In this article

A pediatric program at Mochi Health does not mean that every person under 18 qualifies for medication. Children and adolescents need an assessment appropriate to their age and development, and the exact product has its own evidence and labeling. Adult BMI rules cannot answer the whole question.

This article explains what the provider’s public pediatric pathway establishes and what a family should clarify before enrollment. It does not recommend a medication for a child or treat access to an intake form as clinical approval.

THE SHORT ANSWER

Mochi says it has a separate Pediatrics program for people under 18 and directs families to an eligibility form. This does not establish that every child qualifies for medication or that adult treatment criteria apply.

What to know first

  • Mochi says it has a separate Pediatrics program for people under 18 and directs families to an eligibility form. This does not establish that every child qualifies for medication or that adult treatment criteria apply.
  • Confirm the details against the prescription or plan offered to you.
  • Use the dated sources below and retain the response from the provider.

Can someone under 18 join Mochi Health?

Mochi says it has a separate Pediatrics program for people under 18 and directs families to an eligibility form. This does not establish that every child qualifies for medication or that adult treatment criteria apply.

Use the dedicated pediatric intake with a parent or guardian where required. Ask the pediatric clinician about age, growth, relevant conditions, the exact approved or compounded product, and follow-up. Adult BMI thresholds alone do not answer pediatric eligibility.

    Use the pediatric pathway and ask about the team

    Follow the provider’s dedicated pediatric intake rather than applying through an adult program on assumptions about a cutoff. Ask which ages the service evaluates, who provides the care, and how a parent or guardian participates where required. Confirm which documents or prior records the clinician wants before the visit.

    A useful discussion includes growth, medical history, other treatments, and the family’s goals. Ask the clinician to identify the exact medication being considered and explain the evidence relevant to that patient. An adult program’s description of a compound or a familiar brand name is not a substitute for that review.

      Clarify follow-up, communication, and cost

      Ask how progress will be assessed, how follow-up appointments are arranged, and which contact route is available between visits. Confirm the clinical and administrative roles of the pediatric team. If the program uses a separate portal or consent process, ask how access is managed for the family.

      Obtain the fees and refund terms before payment, including what happens if medication is not appropriate. Enrollment can lead to an assessment without leading to the requested prescription. Keep questions about treatment with the pediatric clinician, and do not borrow an adult dosing schedule or another child’s plan. The published program is a route to an evaluation, not a universal medication offer.

        Separate Mochi membership from the prescription

        Mochi’s public information describes membership and medication as distinct parts of the program. That distinction affects price comparisons, a requested pause, and the work needed before another prescription. Identify both parts in the account and ask which action affects each. If an appointment or clinical response is needed, administrative availability does not establish immediate prescriber access. Keep the provider’s current quote and the selected membership term, especially when a first-month offer is involved. The practical question is what your next payment buys and what care remains outstanding, not merely whether the portal account is active.

          What BMI and health criteria apply to Mochi Health?

          Mochi’s eligibility article describes BMI greater than 30, or greater than 27 with a weight-related condition, and also identifies prior weight-loss medication or weight regain after bariatric surgery as reasons for assessment. Its FAQ distinguishes joining the service from qualifying for a prescription.

          The article uses greater-than wording, while general NIDDK guidance uses 30 or above and 27 or above with a condition. Ask the clinician about a boundary value or continuing-care history; a calculator is not a final prescribing decision.

          For the supporting details, read What BMI and health criteria apply to Mochi Health?.

            Can I switch to Mochi Health while continuing an existing prescription?

            Mochi’s FAQ says it can continue a previous dose when documentation of the prior medication is supplied. Treat this as the company’s stated pathway: the receiving clinician still needs to evaluate the actual prescription, medical history, and any treatment gap.

            Bring the prescription, dispensing label, last treatment date, and recent clinician notes. Ask what documentation is accepted and whether a new prescription and pharmacy fill are required. Do not assume syringe units transfer between concentrations.

            For the supporting details, read Can I switch to Mochi Health while continuing an existing prescription?.

              Sources & research notes

              Checked September 23, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

              1. FAQ | Mochi HealthProvider-published information · Checked September 23, 2026
              2. How to Qualify for Weight Loss Medications | Mochi HealthProvider-published information · Checked September 23, 2026
              3. Prescription Medications to Treat Overweight & Obesity - NIDDKMedical reference · Checked September 23, 2026
              4. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDARegulatory / public agency · Checked September 23, 2026
              5. New Per-Dose Pricing: What Changed | Mochi HealthProvider-published information · Checked September 23, 2026

              Read our methodology · Commercial disclosure · Request a correction